# PhaseV

Source: https://onco.cc/companies/phasev/  
OnCo record `phasev` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

PhaseV provides software for planning and analysing clinical trials, including cancer studies.

## Summary

PhaseV describes clinical trial design and analysis software using statistical modelling and causal inference. Its oncology work with iOMEDICO uses cancer real-world data to select covariates, patient characteristics used to adjust comparisons between trial groups. The cited page discusses oncology trial methods rather than a treatment. Claims about faster recruitment or improved trial success are not treated here as independently established outcomes.

## Fields

- Kind: Company
- Last checked: 2026-11-06
- HQ: Boston / Tel Aviv (offices)
- Type: ai-software
- Website: https://www.phasevtrials.com/

## Notes

- The contact page lists offices in Boston, USA, and Tel Aviv, Israel, without identifying a sole headquarters. US identifies the listed Boston office, not exclusive operations.

## Sources

- Oncology trial covariate adjustment: https://www.phasevtrials.com/resources/advancing-oncology-trials-with-covariate-adjustment
- Official location evidence: https://www.phasevtrials.com/contact
- Elicit AI for Pharma market map: https://elicit.com/ai-for-pharma

## Connected records

- fronts: [AI & Computation](https://onco.cc/fronts/ai-computation/), [Drug Discovery Platforms](https://onco.cc/fronts/drug-discovery/)
- collections: [Elicit AI for Pharma market map](https://onco.cc/collections/elicit-ai-for-pharma/)

---
JSON: https://onco.cc/api/v1/entities/phasev.json